Zhi-Ming Shao
4PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Sep 10, 2025
Interferon-induced senescent CD8+ T cells reduce anti-PD1 immunotherapy efficacy in early triple-negative breast cancer.Tong Fu, Xi Jin, Min He
|Aug 18, 2025
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer.Xiu-Zhi Zhu, Hu-Yun-Long Zhang, Yi-Fan Zhou
|Aug 26, 2024
Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.Yu-Wei Li, Lei-Jie Dai, Xiang-Rong Wu
|Mar 26, 2022
Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial.Song-Yang Wu, Ying Xu, Li Chen
Pageof 1
Frequent Collaborators
3 joint publications
Xi Jin
3 joint publications
Zhi-Ming Shao
3 joint publications
Yi-Zhou Jiang
2 joint publications
Yi-Yu Chen
2 joint publications
Hu-Yun-Long Zhang
2 joint publications
Yi-Fan Zhou
1 joint publications
Lei-Jie Dai
1 joint publications
Xiang-Rong Wu
1 joint publications
Rong-Hua Liu
1 joint publications
Yu-Zheng Xu
